Antiviral treatment of SARS: can we draw any conclusions?

2003; National Institutes of Health; Volume: 169; Issue: 11 Linguagem: Inglês

Autores

Getu Zhaori,

Tópico(s)

Viral Infections and Immunology Research

Resumo

Now that a novel coronavirus has been well established as the cause of severe acute respiratory syndrome (SARS),[1][1],[2][2] it is important to evaluate what we have learned about the antiviral therapy of SARS. Is ribavirin effective? What other antiviral agents have been tried? What do we know

Referência(s)